Accelerating returns by connecting Japanese innovations to global expertise

By building ventures that leverage engineered biology, we're bridging the divide between Japan's pioneering research and the global market.

Our Story

About Saisei Ventures

サイセイベンチャーズについて

Our Story Shapes

Saisei Ventures is a leading venture capital firm focused on growing and harnessing the Japanese biotech ecosystem; a region rich in opportunities and potential. We create ventures that start from bold ideas and empower dynamic entrepreneurs by filling in technical, operational, or financial gaps. Our approach combines Western expertise and Japanese innovation to build globally competitive companies that will have the greatest impact on patient lives.

HOW WE OPERATE

Building transformative biotech companies from revolutionary science.

We identify the latest scientific advancements and pair it with global business and development experience to create life-changing innovations. Our comprehensive approach involves working closely with leading scientists, industry experts, and entrepreneurs to bring their visions to life.

Learn How

arrow-right

WHAT SAISEI HELPS WITH

Bridging the gap between Japan’s pioneering research and international capital investment.

We are dedicated to investing in untapped and cutting-edge life science ecosystems such as Japan. With our unique combination of Western expertise and Japanese innovation, we are able to identify the most promising investment opportunities and bring them to the global market.

Learn How

arrow-right

Where We Invest

Investing in Innovation

イノベーションに投資する

We believe that true innovation occurs at the intersection of sound science and fearless leadership, and we're proud to build biotech ventures that will revolutionize the way we treat disease.

Advanced Therapeutic Platforms

We support emerging modalities like cell immunotherapies, pluripotent cell replacement therapies, and in vivo / ex vivo gene therapy approaches.

Scalable and Manufacturable

We support programs with a reasonable path to clinical and commercial scale manufacturing.

From POC to IND

We support bold ideas with a demonstrated path to the clinic.

Life-Threatening or Debilitating Diseases

We are indication agnostic but are dedicated to addressing serious diseases.

Global Opportunities with Japanese Focus

We source and combine technologies from our broad global network with a focus on Japan

Our Team

Meet Our Team

チームに会う

Get to know the experts behind Saisei Ventures. Meet the talented team driving our mission to revolutionize biotech.

View Our Team

arrow-right
Meet the team

News

Featured News

注目のニュース

New

Saisei Ventures Invests in United Immunity, Co., Ltd., to Develop New Cancer Immune-Therapeutics Using Proprietary Immune Cell-Selective Delivery Technology

09/11/2023

Saisei News

New

Saisei Ventures Enters into Letters of Intent with Healios and will Launch a Special Opportunities Co-Investment Fund

07/10/2023

Saisei News

Saisei Ventures is Selected as a Certified VC Fund by AMED to Catalyze the Japanese Drug Development Ecosystem

05/17/2023

Saisei News

Sign Up for Our Newsletter

Saisei Ventures

© 2024 Saisei Ventures

Home

ホーム

Home

News

Company

会社

About

Team

Portfolio

Contact

コンタクト

Contact

linkedin